| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $5.22 ▲ +1.15% | Yesterday | $5.14 ▼ -0.48% | Tomorrow's YD Bio Limited Ordinary Shares (YDES) setup is anchored to $5.16 and targets $5.22 (+1.15%). The near-term read is upside; watch $5.31 / $5.01 because daily realized volatility is about 5.93%. |
Tomorrow's YD Bio Limited Ordinary Shares (YDES) setup is anchored to $5.16 and targets $5.22 (+1.15%). The near-term read is upside; watch $5.31 / $5.01 because daily realized volatility is about 5.93%. | ||||
| Week | $5.34 ▲ +3.58% | Last Week | $5.08 ▼ -1.50% | The 7-day YD Bio Limited Ordinary Shares model moves from $5.08 to $5.34 (+3.58%). It gives upside momentum context for this stock, so breaks around $5.31 / $5.01 matter more than a single tick. |
The 7-day YD Bio Limited Ordinary Shares model moves from $5.08 to $5.34 (+3.58%). It gives upside momentum context for this stock, so breaks around $5.31 / $5.01 matter more than a single tick. | ||||
| Month | $5.55 ▲ +7.61% | Last Month | $4.99 ▼ -3.20% | The 1-month YD Bio Limited Ordinary Shares target is $5.55 (+7.61%), compared with the live reference near $5.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month YD Bio Limited Ordinary Shares target is $5.55 (+7.61%), compared with the live reference near $5.16. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $5.87 ▲ +13.67% | Last Year | $4.86 ▼ -5.74% | The 1-year YD Bio Limited Ordinary Shares scenario points to $5.87 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year YD Bio Limited Ordinary Shares scenario points to $5.87 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $6.60 ▲ +27.86% | 5 Years Ago | $4.56 ▼ -11.70% | The 5-year YD Bio Limited Ordinary Shares view is $6.60 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year YD Bio Limited Ordinary Shares view is $6.60 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $5.16 | Mid |
| Daily Change | -2.83% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $5.16 | Daily Change | -2.83% |
| Market Cap | $363.89M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.